Directorate Change

RNS Number : 8182U
Victrex PLC
20 May 2008
 





20 May 2008


Victrex plc


Board Changes


Peter Warry has informed the Company of his intention to step down as non-executive Chairman and as Director of the Company with effect from 30 September 2008. He will be succeeded as Chairman by Anita Frewcurrently the Senior Independent Director.


Anita joined Victrex as a non-executive Director in 2000 and is the Chairman of the Remuneration Committee. She is currently a non-executive Director of Aberdeen Asset Management plc, The City of London Investment Trust plc, IMI plc, Northumbrian Water Limited and Securities Trust of Scotland plc.


David Hummel, Chief Executive said,


'Peter has made an invaluable contribution to the Board and the Company with more than nine years of service to Victrex as Chairman. He has guided us through a period of significant growth, development and investment. He has our very best wishes for the future.


am delighted to welcome Anita as our new Chairman in October. Anita has already made a significant contribution to the Board and brought a wide range of experience, particularly in the areas of international marketing, corporate development and the City. I look forward to working with her in her new role.'


No further information in relation to Anita Frew is required to be disclosed pursuant to Listing Rule 9.6.13R.


As at 19 May 2008Anita had beneficial interest of 9,184 shares in the share capital of the Company.


- Ends -


For further information please contact:


Victrex plc


David Hummel, Chief Executive

Michael Peacock, Finance Director




0207 357 9477 (20 May 2008)

01253 897700 (thereafter)

Hogarth Partnership Limited

 

Nick Denton / Barnaby Fry                                                        0207 357 9477

 



Victrex plc is an innovative, world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.


VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis and temperature resistance, as well as excellent dimensional, mechanical and chemical stability combined with inherent purity and low flammability.


End users specify VICTREX PEEK to reduce systems costs, improve part performance, exploit greater design freedom and create a differentiated application.  


VICTREX PEEK is used across a broad range of applications in diverse markets including transport, industrial, electronics and medical. Invibio®, Victrex's biomaterials business, provides specialised solutions for medical device manufacturers.


The Group's headquarters are in the UK where its manufacturing facilities are based. This is complemented by a global network of sales, distribution and technical centres that serve more than 30 countries worldwide. Our team of dedicated market-development, sales and technical support professionals work with customers around the world offering assistance in new application development, product performance data and processing support.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAKSNFAXPEFE

Companies

Victrex plc (VCT)
UK 100